OptiNose, Inc. (OPTN)
USD 9.1
(0.33%)
USD 9.1
(0.33%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 8.05 Million USD | -14.73% |
| 2022 | 9.44 Million USD | -20.29% |
| 2021 | 11.84 Million USD | 31.02% |
| 2020 | 9.04 Million USD | 159.53% |
| 2019 | 3.48 Million USD | -51.15% |
| 2018 | 7.13 Million USD | 254.3% |
| 2017 | 2.01 Million USD | 67.61% |
| 2016 | 1.2 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 11.4 Million USD | 10.59% |
| 2024 Q1 | 10.31 Million USD | 28.1% |
| 2023 Q4 | 8.05 Million USD | 0.11% |
| 2023 Q3 | 8.04 Million USD | 4.02% |
| 2023 Q1 | 8.3 Million USD | -12.07% |
| 2023 Q2 | 7.73 Million USD | -6.88% |
| 2023 FY | 8.05 Million USD | -14.73% |
| 2022 Q3 | 10.41 Million USD | -5.09% |
| 2022 FY | 9.44 Million USD | -20.29% |
| 2022 Q1 | 11.38 Million USD | -3.94% |
| 2022 Q2 | 10.97 Million USD | -3.58% |
| 2022 Q4 | 9.44 Million USD | -9.33% |
| 2021 Q3 | 13.16 Million USD | -1.07% |
| 2021 Q4 | 11.84 Million USD | -9.98% |
| 2021 FY | 11.84 Million USD | 31.02% |
| 2021 Q1 | 12.7 Million USD | 40.49% |
| 2021 Q2 | 13.3 Million USD | 4.72% |
| 2020 FY | 9.04 Million USD | 159.53% |
| 2020 Q1 | 5.7 Million USD | 63.86% |
| 2020 Q4 | 9.04 Million USD | -3.05% |
| 2020 Q3 | 9.32 Million USD | 52.26% |
| 2020 Q2 | 6.12 Million USD | 7.29% |
| 2019 FY | 3.48 Million USD | -51.15% |
| 2019 Q1 | 5.71 Million USD | -19.85% |
| 2019 Q2 | 4.26 Million USD | -25.47% |
| 2019 Q3 | 4.4 Million USD | 3.38% |
| 2019 Q4 | 3.48 Million USD | -20.89% |
| 2018 Q4 | 7.13 Million USD | 1.75% |
| 2018 FY | 7.13 Million USD | 254.3% |
| 2018 Q1 | 3.58 Million USD | 77.84% |
| 2018 Q2 | 4.95 Million USD | 38.27% |
| 2018 Q3 | 7 Million USD | 41.6% |
| 2017 Q2 | 1.39 Million USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 FY | 2.01 Million USD | 67.61% |
| 2017 Q4 | 2.01 Million USD | 735.27% |
| 2017 Q3 | 241 Thousand USD | -82.77% |
| 2016 FY | 1.2 Million USD | 0.0% |
| 2016 Q4 | 1.2 Million USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 75.096% |
| Embecta Corp. | 152.1 Million USD | 94.706% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 92.759% |
| Dynavax Technologies Corporation | 53.29 Million USD | 84.89% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 87.73% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 92.284% |
| PainReform Ltd. | - USD | -Infinity% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -18.954% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -40.407% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -894.372% |
| Cosmos Health Inc. | 4.78 Million USD | -68.133% |
| Journey Medical Corporation | 10.2 Million USD | 21.105% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -40.407% |
| Safety Shot Inc | 1.86 Million USD | -330.67% |
| Alpha Teknova, Inc. | 11.59 Million USD | 30.55% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 30.866% |
| Bright Green Corporation | - USD | -Infinity% |
| Procaps Group, S.A. | 96.83 Million USD | 91.685% |
| Theratechnologies Inc. | 6.06 Million USD | -32.74% |
| Harrow Health, Inc. | 10.86 Million USD | 25.904% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -196.138% |
| Biofrontera Inc. | 10.9 Million USD | 26.183% |
| DURECT Corporation | 2.21 Million USD | -262.866% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 89.598% |
| Cronos Group Inc. | 30.33 Million USD | 73.46% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -805199900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -41.287% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 71.5% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -200.772% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -74.688% |
| Radius Health, Inc. | 278.64 Million USD | 97.11% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -140.842% |
| ProPhase Labs, Inc. | 3.84 Million USD | -109.633% |
| Phibro Animal Health Corporation | 265.91 Million USD | 96.972% |
| Procaps Group S.A. | 96.83 Million USD | 91.685% |
| Alvotech | 74.43 Million USD | 89.182% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.768% |
| Rockwell Medical, Inc. | 5.87 Million USD | -37.149% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 36.262% |
| SIGA Technologies, Inc. | 64.21 Million USD | 87.462% |
| Tilray Brands, Inc. | 252.08 Million USD | 96.806% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 79.859% |
| Shineco, Inc. | 1.58 Million USD | -406.885% |
| PetIQ, Inc. | 159.3 Million USD | 94.946% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 5370.392% |
| Incannex Healthcare Limited | -10.01 Million USD | 180.399% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 78.977% |
| Alimera Sciences, Inc. | 1.87 Million USD | -328.526% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 78.634% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -400.003% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -79.612% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -3065.692% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 22.428% |
| Hempacco Co., Inc. | 2.54 Million USD | -216.68% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 89.182% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 83.153% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 87.424% |
| Currenc Group, Inc. | 732.91 Thousand USD | -998.633% |
| Kamada Ltd. | 87.74 Million USD | 90.824% |
| Indivior PLC | 141.79 Million USD | 94.322% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -1571.094% |
| Flora Growth Corp. | 8.5 Million USD | 5.36% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -3065.692% |
| Evolus, Inc. | 10.99 Million USD | 26.787% |
| HUTCHMED (China) Limited | 50.25 Million USD | 83.979% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 92.392% |
| Akanda Corp. | 1.28 Million USD | -525.693% |